- Home
- GROY vs TRNS Comparison
GROY vs TRNS Comparison
Compare GROY & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GROY | TRNS |
|---|---|---|
| Founded | 2020 | 1964 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Electrical Products |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.4M | 799.0M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GROY | TRNS |
|---|---|---|
| Price | $3.39 | $91.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $5.90 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 2.4M | 123.2K |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $331,877,000.00 |
| Revenue This Year | $145.80 | $21.75 |
| Revenue Next Year | $60.03 | $7.55 |
| P/E Ratio | ★ N/A | $655.50 |
| Revenue Growth | N/A | ★ 19.20 |
| 52 Week Low | $2.45 | $50.23 |
| 52 Week High | $5.45 | $100.00 |
Technical Indicators
Market Signals| Indicator | GROY | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 72.68 | 50.87 |
| Support Level | $3.29 | $85.90 |
| Resistance Level | $3.89 | $94.58 |
| Average True Range (ATR) | 0.11 | 4.74 |
| MACD | 0.05 | -0.13 |
| Stochastic Oscillator | 91.48 | 48.88 |
Price Performance
Historical ComparisonAbout GROY Gold Royalty Corp.
Gold Royalty Corp is principally engaged in acquiring gold-focused royalties, streaming, and similar interests. It is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. The Company operates in Bosnia and Herzegovina, Canada, which generates maximum revenue, the USA, Brazil, and Mexico.
About TRNS Transcat Inc.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.